The Role of Menarcheal Age and Parity in the Development of Uterine Leiomyoma

In: Journal of Health Sciences and Medical Development · 2025 · vol. 4(03) , pp. 144–154 · doi:10.56741/hesmed.v4i03.1415 · W7162035565
article OA: diamond CC0
AI-generated summary by claude@2026-06, 2026-06-07

This case-control study found a significant association between earlier age at menarche and uterine leiomyoma incidence, but no significant association with parity.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

AI-generated deep summary by claude@2026-06, 2026-06-07 · read from full text

This case-control study evaluated whether age at menarche and parity are associated with uterine leiomyoma by comparing 73 histopathologically confirmed leiomyoma cases to 40 adenomyosis controls at PKU Muhammadiyah Hospital Surakarta, using Chi-Square tests and logistic regression. The analysis found a statistically significant association between age at menarche and uterine leiomyoma incidence (p = 0.007; OR = 1.65, 95% CI = 1.414–1.939), while parity showed no significant association (p = 0.384; OR = 1.509, 95% CI = 0.596–3.825). A limitation explicitly noted by the authors is that future work should include more balanced sample group proportions and additional risk factors for a more comprehensive understanding of leiomyoma etiology. Relevance to endometriosis: the study does not explicitly discuss endometriosis (it uses adenomyosis as the comparator), so it is only indirectly related via the shared uterine/gynecologic pain context that includes endometriosis-adjacent pathology.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

Abstract

Uterine leiomyoma is the most prevalent benign neoplasm of the female reproductive tract during the reproductive years; however, its precise etiology remains incompletely understood. Age at menarche and parity have been proposed as potential risk factors, although previous studies have reported inconsistent findings. This study aimed to evaluate the association between age at menarche and parity with the occurrence of uterine leiomyoma. This research employed a case-control design, in which uterine leiomyoma constituted the case group and adenomyosis served as the control group, conducted at PKU Muhammadiyah Hospital Surakarta. The study included 113 participants, comprising 73 cases of uterine leiomyoma and 40 cases of adenomyosis as controls, identified through histopathological records from 2023. Data were assessed using Chi-Square and logistic regression analyses. The findings revealed that most respondents experienced menarche at a normal age and were either primiparous or multiparous. Statistical testing demonstrated a significant association between age at menarche (p = 0.007; OR = 1.65, 95% CI = 1.414–1.939) and the incidence of uterine leiomyoma, whereas parity was not significantly associated (p = 0.384; OR = 1.509, 95% CI = 0.596–3.825). Future studies are recommended to include more balanced sample group proportions and additional risk factors to obtain a more comprehensive understanding of uterine leiomyoma etiology.
Full text 8,951 characters · extracted from oa-doi-fallback · 3 sections · click to expand

Keywords

case-control study, menarche age, parity, reproductive risk factors, uterine leiomyoma

Abstract

Uterine leiomyoma is the most prevalent benign neoplasm of the female reproductive tract during the reproductive years; however, its precise etiology remains incompletely understood. Age at menarche and parity have been proposed as potential risk factors, although previous studies have reported inconsistent findings. This study aimed to evaluate the association between age at menarche and parity with the occurrence of uterine leiomyoma. This research employed a case-control design, in which uterine leiomyoma constituted the case group and adenomyosis served as the control group, conducted at PKU Muhammadiyah Hospital Surakarta. The study included 113 participants, comprising 73 cases of uterine leiomyoma and 40 cases of adenomyosis as controls, identified through histopathological records from 2023. Data were assessed using Chi-Square and logistic regression analyses. The findings revealed that most respondents experienced menarche at a normal age and were either primiparous or multiparous. Statistical testing demonstrated a significant association between age at menarche (p = 0.007; OR = 1.65, 95% CI = 1.414–1.939) and the incidence of uterine leiomyoma, whereas parity was not significantly associated (p = 0.384; OR = 1.509, 95% CI = 0.596–3.825). Future studies are recommended to include more balanced sample group proportions and additional risk factors to obtain a more comprehensive understanding of uterine leiomyoma etiology. Downloads

References

A. S. Koltsova, O. A. Efimova, and A. A. Pendina, “A View on Uterine Leiomyoma Genesis through the Prism of Genetic, Epigenetic and Cellular Heterogeneity †,” Int. J. Mol. Sci., vol. 24, no. 6, 2023, doi: 10.3390/ijms24065752. DOI: https://doi.org/10.3390/ijms24065752 F. Fitriyanti and M. Machmudah, “Penurunan Intensitas Nyeri pada Pasien Mioma Uteri menggunakan Teknik Relaksasi dan Distraksi,” Ners Muda, vol. 1, no. 1, p. 40, 2020, doi: 10.26714/nm.v1i1.5502. DOI: https://doi.org/10.26714/nm.v1i1.5502 A. F. Fauzan Farma and Y. P. Kurniati, “Analysis of The Incidence of Uterine Leiomyoma Based on Body Mass Index and Neutrophil-Lymphocyte Ratio,” J. La Medihealtico, vol. 5, no. 5, pp. 998–1007, 2024, doi: 10.37899/journallamedihealtico.v5i5.1609. DOI: https://doi.org/10.37899/journallamedihealtico.v5i5.1609 E. Giuliani, S. As-Sanie, and E. E. Marsh, “Epidemiology and management of uterine fibroids,” Int. J. Gynecol. Obstet., vol. 149, no. 1, pp. 3–9, 2020, doi: 10.1002/ijgo.13102. DOI: https://doi.org/10.1002/ijgo.13102 N. S. Meilani et al., “ARTIKEL PENELITIAN Hubungan Usia dan Paritas dengan Kejadian Mioma Uteri di RSUD Al-Ihsan Provinsi Jawa Barat Tahun 2017,” vol. 2, no. 22, pp. 200–203, 2019, [Online]. Available: http://ejournal.unisba.ac.id/index.php/jiks DOI: https://doi.org/10.29313/jiks.v2i1.4346 P. A. Andriani, “Analisis Regresi Faktor Resiko Kejadian Mioma Uteri di RSUD dr. R. Goeteng Tarunadibrata Purbalingga,” Indones. J. Nurs. Res., vol. 1, no. 1, pp. 39–47, 2018, doi: 10.35473/ijnr.v1i1.7. DOI: https://doi.org/10.35473/ijnr.v1i1.7 M. Jamil and I. Andriani, “Penguatan Kemandirian Masyarakat Dalam Deteksi Dan Pemeriksaan Mioma Uteri,” J. Implementasi Pengabdi. Masy. Kesehat., vol. 5, no. 2 (Sept), pp. 41–44, 2023, doi: 10.33660/jipmk.v5i2.101. DOI: https://doi.org/10.33660/jipmk.v5i2.101 S. M. Ascher et al., “ACR Appropriateness Criteria® Fibroids,” J. Am. Coll. Radiol., vol. 19, no. 11, pp. S319–S328, 2022, doi: 10.1016/j.jacr.2022.09.019. DOI: https://doi.org/10.1016/j.jacr.2022.09.019 N. Rudiyanti and R. Imron, “Hubungan Usia Menarche Dan Paritas Dengan Mioma Uteri,” J. Keperawatan, vol. 12, no. 2, pp. 233–239, 2016, [Online]. Available: https://www.poltekkes-tjk.ac.id/ejurnal/index.php/JKEP/article/view/604 K. Putu, “Hubungan Usia Dan Paritas Dengan Kejadian Mioma Uteri di RSUD Wagaya Denpasar Tahun 2016-2017.,” Bali Heal. J., vol. 5, no. 2, 2020. DOI: https://doi.org/10.34063/bhj.v5i2.209 M. Maria Syl D. De La Cruz, Md, And Edward M. Buchanan, “Diagnosis and Management of Uterine Torsion,” Vet. Tech. Llamas Alpacas, Second Ed., pp. 247–251, 2023, doi: 10.1002/9781119860792.ch58. DOI: https://doi.org/10.1002/9781119860792.ch58 A. T. Hartoyo and N. Pangastuti, “Fibroid Uterus dan Infertilitas,” Cermin Dunia Kedokt., vol. 49, no. 3, pp. 143–146, 2022, doi: 10.55175/cdk.v49i3.208. DOI: https://doi.org/10.55175/cdk.v49i3.208 G. A. Vilos et al., “The Management of Uterine Leiomyomas,” J. Obstet. Gynaecol. Canada, vol. 37, no. 2, pp. 157–178, 2015, doi: 10.1016/S1701-2163(15)30338-8. DOI: https://doi.org/10.1016/S1701-2163(15)30338-8 A. Wozniak and S. Wozniak, “Ultrasonography of uterine leiomyomas,” Prz. Menopauzalny, vol. 16, no. 4, pp. 113–117, 2017, doi: 10.5114/pm.2017.72754. DOI: https://doi.org/10.5114/pm.2017.72754 S. Rokhgireh et al., “Hemoperitoneum due to bleeding from a vein overlying a subserous uterine myoma: A case report,” J. Med. Case Rep., vol. 14, no. 1, pp. 14–17, 2020, doi: 10.1186/s13256-020-02383-z. DOI: https://doi.org/10.1186/s13256-020-02383-z H. Reza, N. A. Andriani, and S. A. Suwantari, “Cervical Leiomyoma in Pre-Menopausal Woman: A Case Report,” J. Biomed. Transl. Res., vol. 8, no. 3, pp. 145–148, 2022, doi: 10.14710/jbtr.v8i3.16046. DOI: https://doi.org/10.14710/jbtr.v8i3.16046 C. G. Pattinasarany, N. Riyanti, H. Rahawarin, A. Resnawaldi, J. Sinanu, and M. M. Maelissa, “Karakteristik Status Obstetri Pada Pasien Mioma Uteri Di Rsud Dr. M. Haulussy Ambon Tahun 2018-2021,” PAMERI Pattimura Med. Rev., vol. 5, no. 1, pp. 31–39, 2023, doi: 10.30598/pamerivol5issue1page31-39. DOI: https://doi.org/10.30598/pamerivol5issue1page31-39 Y. A. Romadhon and Y. P. Kurniati, “Pathway Pengaruh Lingkungan dalam Inisiasi dan Progresivitas Kanker Tulang dan Jaringan Lunak,” Muhammadiyah University Press, 1st, 2024, ISBN 678-602-361-642. A. S. Dzakwan, N. F. Ngo, H. Nugroho, A. R. Magdaleni, and E. Sawitri, “Hubungan Paritas, IMT, Usia Menarche, Hipertensi, dan Riwayat Keluarga dengan Kejadian Mioma Uteri di RSUD Abdul Wahab Sjahranie Samarinda,” J. Verdure, vol. 3, no. 1, pp. 45–56, 2021. A. M. Handayani, A. A. P. F. Sari, and R. Ulandari, “Hubungan Usia Menarche Dengan Mioma Uteri Di Rs Sungai Kambang,” Midwifery Heal. J., vol. 8, no. 1, 2023, doi: 10.52524/midwiferyhealthjournal.v8i1.178. DOI: https://doi.org/10.52524/midwiferyhealthjournal.v8i1.178 R. Sahari, “Hubungan Paritas Dengan Kejadian Mioma Uteri Di Rumah Sakit Abdul Manap Kota Jambi Rini,” J. Kesehatan., 2022. P. N. Lubis, “Diagnosis dan Tatalaksana Mioma Uteri,” Cermin Dunia Kedokt., vol. 47, no. 3, pp. 1–5, 2020. DOI: https://doi.org/10.55175/cdk.v47i3.352 S. H. Amalia et al., “Faktor-faktor yang Memengaruhi Menarche Dini pada Remaja Perempuan Factors Influencing Early Menarche in Adolescent Girls,” J. Medula, vol. 14, pp. 2236–2248, 2024. K. and R. Handayani, “Gambaran Kesiapan Remaja Dalam Menghadapi Menarche Di Sdit Aisyiyah Full Day Pandes Wedi Klaten,” J. Kebidanan, vol. 8, no. 01, pp. 37–47, 2016, doi: 10.35872/jurkeb.v8i01.198. DOI: https://doi.org/10.35872/jurkeb.v8i01.198 M. Hipson, E. K. Anggraini, P. Studi, D. Kebidanan, and S. A. Palembang, “Analisis Faktor-Faktor Yang Berhubungan Dengan Persalinan Normal,” vol. 13, no. 2, pp. 89–100, 2021. DOI: https://doi.org/10.36729/bi.v13i2.747 R. Sparic, L. Mirkovic, A. Malvasi, and A. Tinelli, “Epidemiology of uterine myomas: A review,” Int. J. Fertil. Steril., vol. 9, no. 4, pp. 424–435, 2016. A. Ciavattini et al., “Uterine Fibroids: Pathogenesis and Interactions with Endometrium and Endomyometrial Junction,” Obstet. Gynecol. Int., vol. 2013, pp. 1–11, 2013, doi: 10.1155/2013/173184. DOI: https://doi.org/10.1155/2013/173184 Nufra, Y. A., & Azimar, A. (2018). Hubungan Faktor Risiko dengan Kejadian Leimioma Uteri di RSUD dr. Zainoel Abidin Banda Aceh. Journal Of Healthcare Technology And Medicine, 4(2). https://doi.org/10.33143/jhtm.v4i2.217 DOI: https://doi.org/10.33143/jhtm.v4i2.217 N. Nadila and N. N. Zulala, “Faktor-faktor yang berhubungan dengan kejadian mioma uteri di RS PKU Muhammadiyah Gamping , Sleman Yogyakarta Factors related to the incident of uterine myoma at PKU Muhammadiyah Gamping Hospital , Sleman Yogyakarta,” Pros. Semin. Nas. Penelit. dan Pengabdi. Kpd. Masy., vol. 2, no. September, pp. 1220–1228, 2024. Y. Duan et al., “Correlation between inflammatory marker and lipid metabolism in patients with uterine leiomyomas,” Front. Med., vol. 10, no. May, pp. 1–9, 2023, doi: 10.3389/fmed.2023.1124697. DOI: https://doi.org/10.3389/fmed.2023.1124697 Downloads Published How to Cite Issue Section License Copyright (c) 2025 Elvina Fawwaz Maharizdihar, Yuni Prastyo Kurniati This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

Ask this paper AI returns verbatim quotes from the full text · source: oa-doi-fallback

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Condition tags

adenomyosis

Citation neighborhood (sparse)

Too few in-corpus citations on either side for a chart; here are the lists.

Cites (1)

References (23)

Source provenance

openalex
last seen: 2026-06-04T00:00:01.174412+00:00
License: CC0 · commercial use OK